MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 158 filers reported holding MERSANA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,368,032 | +6.6% | 5,801,600 | +176.3% | 2.23% | +4.5% |
| Q2 2023 | $6,909,000 | +211.3% | 2,100,000 | +288.8% | 2.14% | +133.3% |
| Q1 2023 | $2,219,642 | -66.8% | 540,059 | -52.6% | 0.92% | -52.1% |
| Q4 2022 | $6,681,467 | -0.6% | 1,140,182 | +14.7% | 1.91% | -15.9% |
| Q3 2022 | $6,720,000 | +71.1% | 994,073 | +16.9% | 2.27% | +88.0% |
| Q2 2022 | $3,927,000 | +131.1% | 850,000 | +579.3% | 1.21% | +59.5% |
| Q2 2021 | $1,699,000 | +319.5% | 125,123 | +400.5% | 0.76% | +243.0% |
| Q1 2021 | $405,000 | +41.6% | 25,000 | +132.3% | 0.22% | +33.1% |
| Q4 2020 | $286,000 | – | 10,763 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 1,191,271 | $6,980,848 | 6.79% |
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $50,769 | 5.67% |
| ACUTA CAPITAL PARTNERS, LLC | 950,000 | $5,567,000 | 3.43% |
| Sarissa Capital Management LP | 3,997,010 | $23,422,479 | 2.79% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $5,299,010 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,140,182 | $6,681,467 | 1.91% |
| Orbimed Advisors | 9,011,437 | $52,807,021 | 1.01% |
| Opaleye Management Inc. | 460,000 | $2,695,600 | 0.94% |
| Artal Group S.A. | 2,200,000 | $12,892 | 0.72% |
| DAFNA Capital Management LLC | 413,463 | $2,422,893 | 0.68% |